ABOUT IR MEDTEK
IR Medtek LLC was founded in early 2019 by Doug Cohen, three other co-founders, and in collaboration with the Ohio State Innovation Fund. The company is the licensor of ground-breaking technology developed at The Ohio State University and the James Cancer Hospital for the early non-invasive diagnosis of skin and other cancers.
The company is currently conducting further research on this technology ahead of a planned clinical study in 2020. Upon validation of the technology in a clinical context, the company will proceed with commercialization of its technology, for which it expects there to be multiple applications. The company's mission is to improve healthcare outcomes through timely, accurate and non-invasive detection of cancers.